Science Applications International Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $7.4B-1.0% YoYTTM through 31 Jul 2026
Net Income $380M-20.3% YoYTTM through 31 Jul 2026
Free Cash Flow $619MTTM through 31 Jul 2026
Margins
| Current | |
|---|---|
| Gross Margin | 12.0% |
| EBITDA Margin | 8.4% |
| Operating Margin | 7.2% |
| Net Margin | 5.1% |
Returns
23.9%ROE
6.7%ROA
10.0%ROIC
Balance Sheet Health
Debt / Equity1.48x
Current Ratio1.20x
Net Debt$2B
Cash & Equivalents$126M
Quality Metrics
Altman Z-Score2.97
Piotroski F-Score6 / 9
FCF Margin8.4%
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2026: $7.3B
Diluted EPS$8.58TTMFY2026: $7.70
Dividend
$1.11Per share, FY20260.86%Yield-5.6%5-yr growth
Capital Allocation
R&D Spend$13M
Capex Intensity0.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Defense and Intelligence | $4.2B | -2.7% | View detailsFocusing on high-end national security solutions and technology integration across defense and space missions. |
| Civilian | $1.3B | -0.7% | View detailsTargeting technology transformation and execution upside in federal, state, and local civilian agency programs. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.